Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models. | Science | 2022 | 35857620 | PubTator, text mining | PubMed |
| Bioinformatic analysis of cancer-associated fibroblast related gene signature as a predictive model in clinical outcomes and immune characteristics of gastric cancer. | Ann Transl Med | 2022 | 35845527 | PubTator, text mining | PubMed |
| SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. | Front Immunol | 2022 | 35844556 | PubTator, text mining | PubMed |
| Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. | Clin Med Insights Oncol | 2022 | 35837368 | PubTator, text mining | PubMed |
| Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma. | Front Med (Lausanne) | 2022 | 35836939 | PubTator, text mining | PubMed |
| DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph. | BMC Bioinformatics | 2022 | 35831792 | PubTator, text mining | PubMed |
| AACR Project GENIE: 100,000 Cases and Beyond. | Cancer Discov | 2022 | 35819403 | PubTator, text mining | PubMed |
| Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer. | J Big Data | 2022 | 35818395 | PubTator, text mining | PubMed |
| Identification of Pyroptosis-Related Gene Signatures and Construction of the Risk Model to Predict BCR in Prostate Cancer. | Front Mol Biosci | 2022 | 35813821 | PubTator, text mining | PubMed |
| Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies. | Acta Neuropathol Commun | 2022 | 35810298 | PubTator, text mining | PubMed |
| Breast Cancer Genomics: Primary and Most Common Metastases. | Cancers (Basel) | 2022 | 35804819 | PubTator, text mining | PubMed |
| Nuclear Mechanosensation and Mechanotransduction in Vascular Cells. | Front Cell Dev Biol | 2022 | 35784481 | PubTator, text mining | PubMed |
| Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study. | Transl Oncol | 2022 | 35777247 | PubTator, text mining | PubMed |
| A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer. | Front Pharmacol | 2022 | 35774610 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications. | Front Genet | 2022 | 35774512 | PubTator, text mining | PubMed |
| Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression. | NPJ Precis Oncol | 2022 | 35768582 | PubTator, text mining | PubMed |
| Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer. | Aging (Albany NY) | 2022 | 35748788 | PubTator, text mining | PubMed |
| The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. | Front Oncol | 2022 | 35747790 | PubTator, text mining | PubMed |
| Psychosis in Parkinson's Disease: A Lesson from Genetics. | Genes (Basel) | 2022 | 35741861 | PubTator, text mining | PubMed |
| Deep Sequencing of Early T Stage Colorectal Cancers Reveals Disruption of Homologous Recombination Repair in Microsatellite Stable Tumours with High Mutational Burdens. | Cancers (Basel) | 2022 | 35740599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=29